Gernot Stuhler, MDImmunotherapy Lab at University Hospital Würzburg
Gernot Stuhler is a haematologist/oncologist with a strong background in allogeneic stem cell transplantation. He was trained in Immunology at the Max-Planck-Institute in Tübingen and at the Dana Farber Cancer Institute/Harvard Medical School in Boston. During his time at Würzburg University where bispecific T cell engager were clinically developed, he got involved in antibody engineering. Currently, he is heading a group of scientists aiming to improve T cell engaging antibody derivatives and to implement combinatorial immunotargeting strategies.